Zimmer Biomet Holdings, Inc. (ZBH) To Go Ex-Dividend on March 31st

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) declared a quarterly dividend on Monday, February 23rd. Stockholders of record on Tuesday, March 31st will be paid a dividend of 0.24 per share by the medical equipment provider on Thursday, April 30th. This represents a c) annualized dividend and a dividend yield of 1.0%. The ex-dividend date of this dividend is Tuesday, March 31st.

Zimmer Biomet has a dividend payout ratio of 11.5% indicating that its dividend is sufficiently covered by earnings. Research analysts expect Zimmer Biomet to earn $8.87 per share next year, which means the company should continue to be able to cover its $0.96 annual dividend with an expected future payout ratio of 10.8%.

Zimmer Biomet Stock Performance

NYSE:ZBH opened at $99.92 on Wednesday. The stock has a 50-day moving average price of $90.96 and a 200 day moving average price of $95.90. The stock has a market capitalization of $19.55 billion, a P/E ratio of 28.23, a P/E/G ratio of 2.03 and a beta of 0.62. Zimmer Biomet has a 12-month low of $84.59 and a 12-month high of $114.44. The company has a current ratio of 1.98, a quick ratio of 1.10 and a debt-to-equity ratio of 0.55.

Zimmer Biomet (NYSE:ZBH) last posted its quarterly earnings results on Tuesday, February 10th. The medical equipment provider reported $2.42 earnings per share for the quarter, topping the consensus estimate of $2.38 by $0.04. The business had revenue of $2.24 billion during the quarter, compared to the consensus estimate of $2.22 billion. Zimmer Biomet had a return on equity of 12.93% and a net margin of 8.56%.The firm’s revenue for the quarter was up 10.9% compared to the same quarter last year. During the same period in the prior year, the company posted $2.31 EPS. Zimmer Biomet has set its FY 2026 guidance at 8.300-8.450 EPS. Equities research analysts forecast that Zimmer Biomet will post 8.22 EPS for the current fiscal year.

About Zimmer Biomet

Zimmer Biomet (NYSE: ZBH) is a global medical device company focused on musculoskeletal healthcare. Headquartered in Warsaw, Indiana, the company designs, manufactures and markets a broad portfolio of products used to treat joint disorders, bone disorders and related conditions. Its customer base includes orthopaedic and dental surgeons, hospitals, ambulatory surgery centers and other healthcare providers that rely on implants, instruments and related services for reconstructive and restorative procedures.

The company’s product offerings span joint replacement systems for hips, knees and shoulders; trauma and extremities implants; spine and thoracic solutions; dental and craniomaxillofacial implants and prosthetics; and sports medicine devices.